CN Stock MarketDetailed Quotes
300463 Maccura Biotechnology
- 13.75
- +0.19+1.40%
Market Closed Dec 27 15:00 CST
8.42BMarket Cap25.89P/E (TTM)
13.75High13.48Low44.18KlotVolume13.56Open13.56Pre Close60.35MTurnover0.90%Turnover Ratio26.96P/E (Static)612.47MShares17.3152wk High1.29P/B6.76BFloat Cap9.7552wk Low16.27Limit Up491.50MShs Float63.84Historical High10.85Limit Down1.99%Amplitude9.10Historical Low0.15Dividend TTM13.66Avg Price20.00KlotAsk1.12%Div YieldTTM100Lot Size23.58KlotBid
Maccura Biotechnology Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -7.92%1.95B | -7.37%1.28B | -8.88%616.37M | -19.75%2.9B | -22.19%2.12B | -22.51%1.38B | -26.85%676.4M | -9.35%3.61B | -9.67%2.72B | -9.11%1.78B |
| Operating revenue | -7.92%1.95B | -7.37%1.28B | -8.88%616.37M | -19.75%2.9B | -22.19%2.12B | -22.51%1.38B | -26.85%676.4M | -9.35%3.61B | -9.67%2.72B | -9.11%1.78B |
| Other operating revenue | ---- | -30.95%12.64M | ---- | -15.50%33.95M | ---- | -8.67%18.31M | ---- | -13.54%40.18M | ---- | 5.01%20.05M |
| Total operating cost | -6.15%1.64B | -6.10%1.08B | -9.25%483.29M | -9.30%2.51B | -13.19%1.75B | -11.49%1.15B | -18.55%532.54M | -0.58%2.76B | 1.11%2.02B | 1.60%1.3B |
| Operating cost | -12.54%833.71M | -14.57%549.93M | -13.13%262.5M | -21.58%1.3B | -25.72%953.2M | -20.88%643.7M | -28.35%302.17M | -1.32%1.65B | 2.34%1.28B | -0.96%813.53M |
| Operating tax surcharges | -6.50%15.9M | -2.64%11.85M | -10.33%4.03M | -21.40%27.14M | -28.14%17.01M | -30.77%12.17M | -36.51%4.5M | -3.03%34.53M | -6.55%23.67M | 0.32%17.58M |
| Operating expense | 2.07%437.35M | 0.41%287.66M | -5.49%120.71M | 3.58%652.41M | -0.05%428.47M | 1.86%286.48M | -5.50%127.73M | -1.03%629.87M | 1.30%428.66M | 9.00%281.26M |
| Administration expense | -0.12%117.4M | 11.05%77.03M | -2.63%32.69M | 18.27%184.23M | 16.35%117.54M | 7.12%69.37M | -7.82%33.57M | -7.50%155.77M | 2.39%101.02M | 2.37%64.76M |
| Financial expense | -10.89%14.53M | -8.73%7.44M | -38.48%3.83M | 27.46%23.31M | 36.61%16.31M | -49.21%8.15M | -12.27%6.22M | -68.40%18.29M | -72.48%11.94M | -45.39%16.04M |
| -Interest expense (Financial expense) | -38.57%15.14M | -24.52%11.68M | -2.39%5.95M | -4.34%33.53M | -10.77%24.64M | -18.69%15.47M | -44.57%6.09M | -40.86%35.06M | -39.32%27.62M | -35.19%19.02M |
| -Interest Income (Financial expense) | 44.95%-4.21M | 26.70%-3.6M | 10.43%-1.84M | 16.45%-10.03M | 20.64%-7.65M | 31.23%-4.91M | 59.91%-2.05M | -139.88%-12.01M | -153.26%-9.65M | -175.87%-7.14M |
| Research and development | 2.73%223.1M | 12.39%144.5M | 2.02%59.52M | 18.65%324.17M | 30.17%217.17M | 23.17%128.57M | 25.80%58.35M | 31.82%273.22M | 12.14%166.83M | 19.38%104.39M |
| Credit Impairment Loss | 147.53%9.06M | 934.00%14.05M | -280.58%-4.86M | -6.38%-36.37M | 7.13%-19.07M | 86.10%-1.68M | 90.36%-1.28M | -254.60%-34.19M | -92.82%-20.54M | -22.82%-12.12M |
| Asset Impairment Loss | 87.07%-7.03M | 93.05%-3.44M | 98.15%-93.68K | -142.09%-58.04M | -534.05%-54.33M | -267.39%-49.42M | 44.50%-5.06M | -35.95%-23.97M | -31.55%-8.57M | -117.01%-13.45M |
| Other net revenue | 121.78%12.93M | 153.63%23.53M | 194.88%3.36M | -110.55%-58.05M | -222.89%-59.34M | -253.14%-43.87M | 82.56%-3.55M | -313.01%-27.57M | -2,625.03%-18.38M | -77.15%-12.42M |
| Fair value change income | 43.68%-8.67M | 74.48%-2.22M | 78.08%-1.58M | 22.27%-7.08M | -12.66%-15.39M | -856.58%-8.7M | ---7.22M | ---9.1M | ---13.66M | ---909.8K |
| Invest income | -65.80%3.39M | -66.51%2.65M | -51.15%1.85M | -29.25%8.59M | -21.22%9.92M | 30.42%7.9M | --3.79M | 2,974.97%12.15M | 2,539.81%12.59M | 1,274.20%6.06M |
| -Including: Investment income associates | ---- | ---- | --0 | -87.86%42.22K | -54.90%202.21K | -10.90%202.21K | --138.32K | -11.92%347.88K | 186.87%448.36K | 143.97%226.96K |
| Asset deal income | -84.03%-5.8M | -22.66%-3.43M | -258.71%-1.38M | -1.13%-4.17M | 6.14%-3.15M | -0.15%-2.8M | -100.06%-386.04K | -1.74%-4.12M | -185.49%-3.36M | -404.96%-2.79M |
| Other revenue | -3.18%21.96M | 47.10%15.92M | 42.86%9.44M | 23.17%39.01M | 49.69%22.68M | 0.36%10.82M | 196.88%6.61M | -27.80%31.67M | 4.62%15.15M | 6.58%10.79M |
| Operating profit | 4.08%318.54M | 18.91%224.04M | -2.75%136.45M | -59.49%331.14M | -55.29%306.05M | -60.07%188.41M | -43.99%140.31M | -32.67%817.39M | -32.68%684.47M | -30.23%471.83M |
| Add:Non operating Income | 333.08%1.41M | 919.61%1.37M | 31.79%73.57K | -5.41%378.13K | -4.95%326.02K | 196.18%134.75K | 420.57%55.82K | -28.51%399.73K | 31.02%343.01K | -65.61%45.49K |
| Less:Non operating expense | -19.47%8.67M | -62.33%2.27M | -89.95%535.22K | -8.91%26.15M | -20.71%10.77M | 28.69%6.04M | 192.72%5.32M | 4.41%28.71M | 356.79%13.58M | 126.86%4.69M |
| Total profit | 5.30%311.28M | 22.26%223.14M | 0.70%135.98M | -61.30%305.37M | -55.96%295.6M | -60.93%182.51M | -45.71%135.04M | -33.53%789.08M | -33.80%671.23M | -30.72%467.18M |
| Less:Income tax cost | 2.23%28.19M | 91.53%20.65M | -31.81%11.74M | -99.21%689.9K | -61.09%27.57M | -81.15%10.78M | -52.88%17.22M | -52.74%87.38M | -60.84%70.86M | -51.23%57.2M |
| Net profit | 5.62%283.1M | 17.91%202.49M | 5.45%124.24M | -56.58%304.68M | -55.36%268.03M | -58.11%171.73M | -44.47%117.83M | -29.99%701.71M | -27.93%600.37M | -26.40%409.98M |
| Net profit from continuing operation | 5.62%283.1M | 17.91%202.49M | 5.45%124.24M | -56.58%304.68M | -55.36%268.03M | -58.11%171.73M | -44.47%117.83M | -29.99%701.71M | -27.93%600.37M | -26.40%409.98M |
| Less:Minority Profit | 367.30%1.72M | 124.57%764.15K | 299.05%3.8M | -22.61%-7.94M | -147.77%-645.21K | -173.86%-3.11M | -90.79%952.67K | -114.19%-6.48M | -100.70%-260.41K | -83.41%4.21M |
| Net profit of parent company owners | 4.72%281.37M | 15.38%201.73M | 3.05%120.44M | -55.86%312.62M | -55.27%268.68M | -56.91%174.84M | -42.10%116.87M | -25.97%708.18M | -24.56%600.64M | -23.68%405.77M |
| Earning per share | ||||||||||
| Basic earning per share | 5.65%0.4635 | 16.29%0.332 | 5.26%0.2 | -56.20%0.5136 | -55.72%0.4387 | -57.57%0.2855 | -44.10%0.19 | -32.25%1.1726 | -30.85%0.9907 | -29.65%0.6728 |
| Diluted earning per share | 4.72%0.4594 | 15.38%0.3294 | 5.26%0.2 | -56.19%0.5104 | -55.72%0.4387 | -57.57%0.2855 | -44.10%0.19 | -32.18%1.1651 | -30.70%0.9907 | -29.53%0.6728 |
| Other composite income | 46.52%-9.04M | 86.27%-1.25M | 95.64%-363.65K | -152.74%-8.4M | -215.51%-16.91M | -129.41%-9.12M | -8.33M | 472.55%15.93M | 14.64M | 31.03M |
| Other composite income of parent company owners | 46.52%-9.04M | 86.27%-1.25M | 95.64%-363.65K | -152.74%-8.4M | -215.51%-16.91M | -129.41%-9.12M | ---8.33M | 472.55%15.93M | --14.64M | --31.03M |
| Total composite income | 9.13%274.05M | 23.76%201.24M | 13.14%123.88M | -58.71%296.28M | -59.17%251.12M | -63.13%162.6M | -48.40%109.49M | -28.09%717.63M | -26.18%615.01M | -20.83%441.01M |
| Total composite income of parent company owners | 8.17%272.33M | 20.98%200.47M | 10.63%120.08M | -57.99%304.22M | -59.08%251.77M | -62.06%165.71M | -46.23%108.54M | -23.96%724.11M | -22.72%615.27M | -17.85%436.8M |
| Total composite income of minority owners | 367.30%1.72M | 124.57%764.15K | 299.05%3.8M | -22.61%-7.94M | -147.77%-645.21K | -173.86%-3.11M | -90.79%952.67K | -114.19%-6.48M | -100.70%-260.41K | -83.41%4.21M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
